The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

    Should you take Ginkgo biloba with cilostazol or clopidogrel?

    The effects of cilostazol (Pletal) and clopidogrel (Plavix) on platelet activity do not change when either drug is taken with G. biloba.

    However?

    G. biloba prolongs the time it takes to stop bleeding (as measured by the bleeding time test) caused by Pletal — an effect that occurs independently of the action of Pletal on platelets.

    The results of the study are based on 10 healthy men who took single doses of these drugs in different combinations.

    Some background.

    • Pletal is taken to reduce the symptoms of intermittent claudication (leg weakness associated with blood circulation difficulties) that some people experience when walking.
    • Plavix is used to prevent clotting following heart attack, stroke, or claudication.

    The bottom line?
    According to the MayoClinic.com, G. biloba “is generally well tolerated, but due to multiple case reports of bleeding, should be used cautiously in patients on anti-coagulant [blood thinning] therapy, with known coagulopathy [bleeding disorder], or prior to some surgical or dental procedures.”

    These study results don’t change this recommendation.

    4/30/07 20:46 JR

    Leave a Comment

    XHTML: Line-breaks are automatic. Available tags are <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>